Venlafaxine-associated psoriasiform palmoplantar keratoderma and subungual hyperkeratosis [2]

British Journal of Dermatology

Volumn 154, Issue 5, 2006, Pages 999-1000

  Dalle, S ^a   Becuwe, C ^a   Balme, B ^a   Thomas, L ^a  

^a HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CHLORMETHINE; CLOFAZIMINE; DOCETAXEL; GLUCAN; LITHIUM; RETINOID; SALICYLIC ACID; SEROTONIN UPTAKE INHIBITOR; TEGAFUR; UREA; VENLAFAXINE;

ADULT; ANAMNESIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEPRESSION; HAIR LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; KERATOSIS PALMOPLANTARIS; LETTER; MALE; PARONYCHIA; PRIORITY JOURNAL; PSORIASIFORM PALMOPLANTAR KERATODERMA; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; SUBUNGUAL HYPERKERATOSIS; T CELL LYMPHOMA; XEROSTOMIA;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CYCLOHEXANOLS; DRUG ERUPTIONS; HUMANS; KERATODERMA, PALMOPLANTAR, DIFFUSE; KERATOSIS; MALE; MIDDLE AGED; NAIL DISEASES;

EID: 33645813420     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07197.x     Document Type: Letter

References (10)

1. Gelenberg AJ Lydiard RB Rudolph RL et al. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: a 6-month randomized controlled trial. JAMA 2000 283 3082 8.
2. Pitchot W Ansseau M. Venlafaxine-induced hair loss. Am J Psychiatry 2001 158 1159 60.
3. Weiss NT Jones L Chamberlain JC. A possible case of venlafaxine-induced Stevens-Johnson syndrome. J Clin Psychiatry 2004 65 1431 3.
4. Woo IS Shim KH Kim GY et al. Nail changes during docetaxel containing combination chemotherapy. Korean J Intern Med 2004 19 132 3.
5. Dixit VB Chaudhary SD Jain VK. Clofazimine induced nail changes. Indian J Lepr 1989 61 476 8.
6. Major P. Verapamil as a cause of palmar hyperkeratosis. Tidsskr Nor Laegeforen 1983 103 2061
7. Jucgla A Sais G Navarro M et al. Palmoplantar keratoderma secondary to chronic acral erythema due to tegafur. Arch Dermatol 1995 131 364 5.
8. Duvic M Reisman M Finley V et al. Glucan-induced keratoderma in acquired immunodeficiency syndrome. Arch Dermatol 1987 123 751 6.
9. Labelle A Lapierre YD. Keratodermia: side effects of lithium. J Clin Psychopharmacol 1991 11 149 50.
10. Lambert D Beylot C Mazet J et al. Drug eruptions caused by lithium salts. Ann Med Interne (Paris) 1984 135 637 8.